Moebius Medical
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
27 Habarzel Street Migdalei Orr, Tel Avi...Phone Number
+972 37684932Website
www.moebiusmedical.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Moebius Medical
Moebius Medical is an innovative clinical-stage biotech company founded in 2008, specializing in proprietary liposomal technologies for the treatment of osteoarthritis (OA). Their lead product, MM-II, is a non-opioid intra-articular injection currently in Phase 3 clinical development, designed to provide durable pain relief for OA patients. The company aims to improve the quality of life for the millions suffering from OA by offering novel and effective treatments. Moebius Medical collaborates with partners like Sun Pharma to advance their product pipeline and clinical trials.Explore more
Moebius Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Moebius Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Moebius Medical recently announced quarterly report
Check if Moebius Medical has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Moebius Medical has new funding data
Product Launch: Get notified when Moebius Medical launches new products
Moebius Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Moebius Medical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Moebius Medical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Moebius Medical
Recommended Actions
Reach out to Masked Content who joined Moebius Medical as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Moebius Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Moebius Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Moebius Medical.
Moebius Medical Tech Stack
A closer look at the technologies used by Moebius Medical
Moebius Medical News & Media
Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
MUMBAI, India and TEL AVIV, Israel, Sept. 6, 2024 /PRNewswire/ -- Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Limited, and includes its subsidiaries or associate companies) and Israel-based Moebius Medical Limited announced...Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)
A single intra-articular injection of 3mL of MM-II provided greater pain relief than placebo for up to 26 weeks From weeks 12 to 26, more patients on MM-II experienced a ≥50% improvement in knee OA pain than patients on placebo and used less rescue medication MUMBAI, India and TEL AVIV,...Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel candidate for the treatment of pain in knee osteoarthritis (OA). The Phase IIb clinical trial, which is...Moebius Medical Announces FDA Clearance of IND Application for Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
TEL AVIV, Israel, Dec. 21, 2020 /PRNewswire/ -- Israel-based Moebius Medical today announced that the US Food and Drug administration (FDA) has cleared their Investigational New Drug (IND) application to initiate a global multi-center Phase IIb clinical trial of MM-II, a novel candidate...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Moebius Medical
Sign Up For FreeTo access detailed company insights
Moebius Medical is an innovative clinical-stage biotech company founded in 2008, specializing in proprietary liposomal technologies for the treatment of osteoarthritis (OA). Their lead product, MM-II, is a non-opioid intra-articular injection currently in Phase 3 clinical development, designed to provide durable pain relief for OA patients. The com... Read More
